Pharma Grade CBD Products to be Rescheduled to Schedule V Pharma Grade CBD Products such as Epidiolex will be Schedule V – comparable to codeine-containing cough syrups – indicating a low potential for abuse and effectiveness as a therapeutic drug. The Drug Enforcement Agency published a notification on the FDA CBD rescheduling in the Federal Register. […]
CBD Isolate Drugs Rescheduled by the FDA CBD isolate based drug Epidolex has been removed from Schedule I and placed in Schedule V which will make access to the drug much simpler for patients who can afford it. The rescheduling is a major breakthrough in the medical cannabis and hemp CBD industry because it finally
Will Coca Cola Become an Infused Beverage Leader? Coca-Cola is looking at Cannabis derived ingredient – CBD (Cannabidiol) as a possible ingredient in health drinks. While this may seem strange at first we should remember that Coca Cola started out as a tonic containing botanical extracts including cocaine. Coca-Cola is in talks with a major Canadian
Hemp industry turns to Pharma tech to meet growing demand for Cannabidiol Rhizo Sciences offers large scale CO2 extraction systems to process hemp at industrial scale Seattle, May 10, 2018 The hemp industry is undergoing a renaissance due to an explosion of interest in Cannabidiol, (aka CBD) but it’s struggling to keep up with
Medical Cannabis: Out of Africa Africa is one of the homelands of modern medical cannabis. Many of the most prominent medical cannabis genetics have African Ancestry, and names such as Durban Poison (South African), Malawi Gold, and Moroccan Hash are touchstones for cannabis geneticists. A treasure trove of landrace strains are still preserved around the
Ruatoria-based Hikurangi Group has signed an agreement to work with Rhizo Sciences LLC, a cannabis industry development and distribution company based in Seattle, Washington, USA. Rhizo Sciences develops and manages medical cannabis cultivation, extraction and manufacturing facilities internationally. Their international experience and turnkey systems will enable Hikurangi Group to rapidly expand their Ruatoria medical cannabis
Medical Cannabis is Going Global The medical cannabis industry is booming, growing faster than any industry segment since dot.com boom. It sounds like an investor’s dream: Fast moving, high growth, high return, and a queue of institutional investors waiting on the sidelines to pour in capital following legalisation, including big pharma, big food, big alcohol,
Rhizo Sciences announces Medical Cannabis Exports from Africa in Partnership with Medi Kingdom US firm targets international medical cannabis markets with $45M export partnership with first African medical cannabis producer. Seattle, December 14, 2017. Rhizo Sciences announces construction of 400,000 square foot export facility in Lesotho, Africa to meet growing international demand for medical cannabis.
Most animal studies with cannabidiol utilize synthetic, single-molecule CBD produced by biochemical laboratories for research purposes. In contrast, whole plant extractions typically include CBD, THC, and more than 400 trace compounds. Many of these compounds interact synergistically to create what scientists refer to as an “entourage effect” that magnifies the therapeutic benefits of the plant’s individual components—so that the
Rhizo Sciences is a collective team of industry professionals from Seattle specializing in extraction systems…
